Qiagen N.V. | Ownership

Companies that own Qiagen N.V.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
PRIMECAP Management Co.
16,179,961
7.14%
-73,665
0.43%
06/30/2018
Massachusetts Financial Services Co.
11,746,489
5.19%
105,003
0.15%
06/30/2018
DWS Investment GmbH
10,936,517
4.83%
52,509
0.24%
06/30/2018
Templeton Global Advisors Ltd.
7,343,436
3.24%
-1,565,251
0.73%
06/30/2018
Templeton Investment Counsel LLC
6,595,189
2.91%
-856,056
1.19%
06/30/2018
The Vanguard Group, Inc.
6,313,280
2.79%
53,448
0.01%
06/30/2018
Sycomore Asset Management SA
5,975,260
2.64%
-972,000
7.53%
02/16/2018
BlackRock Fund Advisors
3,971,354
1.75%
-550,771
0.01%
06/30/2018
Hardman Johnston Global Advisors LLC
3,758,339
1.66%
106,960
5.74%
06/30/2018
DZ PRIVATBANK SA
2,673,141
1.18%
-240,699
0.34%
06/30/2018

About Qiagen

View Profile
Address
Hulsterweg 82
Venlo Limburg 5912 PL
Netherlands
Employees -
Website http://www.qiagen.com
Updated 07/08/2019
QIAGEN NV is a holding company, which engages in the manufacture and distribution of sample and assay technology products for preanalytical sample preparations. It provides solutions to customers that are classified into molecular diagnostics, applied testing, pharma, and academia. Its products include instruments, and consumables and related products.